Impact BioMedical Inc. (IBO)
Develops small molecule drugs and wellness products for cancer, inflammation, and viral infections.
$0.43-0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-30.0%
The outlook
IBO is trading near the low end of its 52-week range, well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears thin or unavailable for this micro-cap stock. The overall data paints a bearish picture with minimal bullish signals.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Market cap
$46.4M
52-wk high
$0.83
52-wk low
$0.37
50-day avg
$0.50
200-day avg
$0.53
Trailing P/E
—